NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
anand15 anand15 @anand15.87105
Sep 20, 2018 $13.00 -31.47% $18.97 X 68.50% 0
JS JS Pro
Jul 25, 2018 $10.66 -1.93% $10.87 X 98.07% 0
paoooolo paoooolo @paoooolo.2570
Jul 25, 2018 $11.50 +5.80% $10.87 X 94.20% 0
paoooolo paoooolo @paoooolo.2570
Jun 20, 2018 $12.70 +3.17% $12.31 X 96.80% 0
Jun 20, 2018 $9.75 -20.80% $12.31 X 79.20% 0
paoooolo paoooolo @paoooolo.2570
Jun 15, 2018 $12.00 -5.81% $12.74 X 94.20% 0
paoooolo paoooolo @paoooolo.2570
Jun 4, 2018 $11.00 +17.90% $9.33 X 82.10% 0
Feb 6, 2018 $1.61 -73.03% $5.97 X 27.00% 0
Texasstockman1 Texasstockman1 @Texasstockman1.8741
Oct 25, 2017 $3.04 +10.14% $2.76 X 89.90% 0
JS JS Pro
Oct 24, 2017 $2.71 +2.26% $2.65 X 97.70% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE